SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000905718-19-000065
Filing Date
2019-01-18
Accepted
2019-01-18 16:32:23
Documents
1
Period of Report
2018-12-18

Document Format Files

Seq Description Document Type Size
1 crisprfm4a_dec192018.html 4/A  
1 crisprfm4a_dec192018.xml 4/A 5297
  Complete submission text file 0000905718-19-000065.txt   6622
Mailing Address 601 GATEWAY BOULEVARD SUITE 350 SAN FRANCISCO CA 94080
Business Address
EMSTER KURT VON (Reporting) CIK: 0001252524 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37923 | Film No.: 19533516

Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)